Bio-Rad Laboratories Inc (STU:BUWA)
€ 344.3 4.8 (1.41%) Market Cap: 9.37 Bil Enterprise Value: 9.16 Bil PE Ratio: 0 PB Ratio: 1.39 GF Score: 75/100

Bio Rad Laboratories Inc at Wells Fargo Healthcare Conference Transcript

Sep 07, 2023 / 03:00PM GMT
Release Date Price: €339 (-1.22%)
Timothy Ian Daley
Wells Fargo Securities, LLC, Research Division - Associate Analyst

Great. So perfect. Thank you, guys, for all attending here. My name is Tim Daley. I am the life science tools analyst here at Wells Fargo. We are very happy to have Bio-Rad here with us for a fireside chat. I am joined here by Norman Schwartz, the President and CEO; and Ilan Daskal, CFO. So with that, we'll kick it off. If we have a few minutes at the end, I might open up to the audience. They got a lot of stuff here. So if nobody's got anything, we'll just keep running through.

Questions & Answers

Timothy Ian Daley;Norman D. Schwartz
Wells Fargo Securities, LLC, Research Division - Associate Analyst;Bio-Rad

But so -- just, I guess, to kick things off, lots of month-to-month volatility across both geographies as well as end markets. So it would be great if you guys could just give us an update on how August demand trends came in? Do things sequentially on a month-to-month basis improve, get worse? Anything stand out in particular.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot